T-cells with a single tumor antigen-specific T-cell receptor can be generated in vitro from clinically relevant stem cell sources

Chimeric antigen receptor (CAR) T-cells have shown great promise in the treatment of B-cell malignancies. For acute myeloid leukemia (AML), however, the optimal target surface antigen has yet to be discovered. Alternatively, T-cell receptor (TCR)-redirected T-cells target intracellular antigens, mar...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonte, Sarah, De Munter, Stijn, Goetgeluk, Glenn, Ingels, Joline, Pille, Melissa, Billiet, Lore, Taghon, Tom, Leclercq, Georges, Vandekerckhove, Bart, Kerre, Tessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028335/
https://www.ncbi.nlm.nih.gov/pubmed/32117593
http://dx.doi.org/10.1080/2162402X.2020.1727078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028335/
https://www.ncbi.nlm.nih.gov/pubmed/32117593
http://dx.doi.org/10.1080/2162402X.2020.1727078

Ejemplares similares